This site is intended for Healthcare Professionals only.

Vaccine advisers eye autumn Covid boosters for over-65s


Share post:

The Joint Committee on Vaccination and Immunisation (JCVI) on Thursday (May 19) said that an anticipated autumn Covid booster campaign would be aimed at people aged over 65 (Covid boosters for over-65s), care home residents, frontline health and social care workers and all adults in a clinical risk group.

The UK is offering a spring booster to the over-75s, care home residents and immunosuppressed people, and ministers have spoken openly of plans for a further booster campaign in the autumn.

In interim advice, the JCVI stopped short of recommending another shot for all adults, though said the advice would be reviewed and updated.

“The JCVI’s current view is that in autumn 2022, a Covid-19 vaccine should be offered to: residents in a care home for older adults and staff; frontline health and social care workers; all those 65 years of age and over; and adults aged 16 to 64 years who are in a clinical risk group,” the UK Health Security Agency said in a statement.

Prime minister Boris Johnson, who was fiercely criticised for his handling of the early stages of the pandemic, lifted Covid restrictions in England in February, crediting Britain’s quick initial vaccine rollout and the rollout of boosters with breaking the link between cases and deaths.

The booster programme helped to ensure that a wave of the highly transmissible Omicron variant and record case numbers did not overwhelm the NHS.

“We welcome the interim advice from the JCVI for an Autumn Covid booster programme and will consider their final recommendations later this year,” the Department of Health and Social Care said said.

“We have asked the NHS in England to begin preparations to ensure they are ready to deploy Covid vaccines to those eligible.”


Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

ABPI: Increased pharma exports could boost GDP by £16.3 billion

ABPI urges political leaders to enhance healthcare and economic growth through strategic partnership The Association of the British Pharmaceutical...

The Importance Of Expanding Access To Dental Care For Rural And Undeserved Populations

In many rural areas and underserved neighborhoods, a critical issue is quietly emerging. Although often overlooked, its effects...

BGMA: More than 50% of UK generics face shortages without licensed alternatives

Brexit blamed by BGMA CE, Mark Samuels, as UK faces critical shortages in generic drug supply A recent report...

Paul Burden elected BGMA Vice-Chair, bringing 25 years of industry leadership

Veteran of off-patent sector to drive strategic engagement and patient access initiatives at BGMA The British Generic Manufacturers Association...